Espiritu, Ernesto .

HRN: 29-14-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2026
CEFTAZIDIME 1GM (VIAL)
06/13/2026
06/20/2026
IV
1g
Q8
CAP MR
Checking Initial Appropriateness 
06/13/2026
AZITHROMYCIN 500MG TABLET (TAB)
06/13/2026
06/17/2026
PO
500mg
Od
Capmr
Checking Initial Appropriateness 
06/14/2026
MUPIROCIN 2%, 15G (TUBE)
06/14/2026
06/20/2026
TOPICAL
Apply On Affected Areas
Bid
Bed Sore;
Checking Initial Appropriateness 
06/19/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/19/2026
06/19/2026
IV
4.5gm
LD
Septicemia
Checking Initial Appropriateness 
06/19/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/19/2026
06/25/2026
IV
2.25gm
Q6
Septicemia
Checking Initial Appropriateness 
06/20/2026
MUPIROCIN 2%, 15G (TUBE)
06/20/2026
06/26/2026
TOPICAL
2%
Bid
Pressure Ulcer
Checking Initial Appropriateness 
06/26/2026
RIFAXIMIN 200MG (TAB)
06/26/2026
07/03/2026
PO
400mg
TID
Hepatic Encephalopathy
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: